GlaxoSmithKline Plc said an injection of its cabotegravir drug given every two months, in combination with Johnson & Johnson's rilpivirine, was recommended for approval to treat HIV infections by a ...
Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...
Inovio Pharmaceuticals Inc has received U.S. health regulator's clearance to begin a mid-stage study of its COVID-19 vaccine candidate, the vaccine maker said on Monday.
As semaglutide hits pharmacy shelves for $499, doctors weigh the pros and cons of brand-name vs. compounded meds.
The agency will consider a submission that includes pooled data from ongoing studies, a decision analysts viewed as a notable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback